Federal Appeals Court Rules on Distribution of Mifepristone
A recent federal appeals court ruling has determined that mifepristone, a medication used in the majority of abortions in the U.S., can now only be distributed in person at clinics.
Editorial Staff
1 min read
Updated 7 days ago
The federal appeals court has issued a ruling that significantly alters the distribution of mifepristone, a drug commonly used in abortions across the United States.
Under the new decision, mifepristone will no longer be available for mailing and can only be obtained in person at designated clinics.
This ruling may impact access to the medication for many individuals seeking abortion services, raising concerns about the implications for reproductive health care.